OKYO Pharma Announces Filing of Annual Report with Strengthened Cash Position and Accelerated Phase 3 Plans
OKYO Pharma Reports Positive Feedback from FDA Type D Meeting and Accelerates Urcosimod into Global Phase 3 Pivotal Trial for Neuropathic Corneal Pain
OKYO Expands Scientific Advisory Board with the Appointment of International Expert Marta Sacchetti, MD, PhD
OKYO CEO and CSO to Present and Leadership Team to Participate at Upcoming Scientific Conferences in May
Brixton Metals Enters into Option Agreement to Acquire a 100% Interest in the Silver Focused Silvergruvan Project in Sweden
Nevada Sunrise Announces Results of Soil Sampling Program at the Fivemile Gold Project, Cortez Mining District, Nevada
SAGA Metals Drills 485.4 m at 32.21% Fe2O3, 5.30% TiO2, 0.191% V2O5 Including 56.8 m at 49.56% Fe2O3, 8.17% TiO2, 0.339% V2O5 at Radar Critical Minerals Project in Labrador
